Name | 4-piperidin-1-ylpiperidine-1-carbonyl chloride |
---|---|
Synonyms |
1-Chlorocarbonyl-4-Piperidinopiperidine
piperidinylpiperidinylchlorocarbonylamide <1,4'>bipiperidinyl-1'-carbonyl chloride 1,4'-dipiperidine-1-carbonyl chloride 4-Piperidinopiperidine-1-carbonyl Chloride 1-chlorocarbonyl-4-piperidinopiperidine 1,4'-bipiperidine-1'-carbonyl chloride 4-piperidino-1-piperidinecarbonyl chloride 4-piperidinopiperidinocarbonyl chloride |
Molecular Formula | C11H19ClN2O |
---|---|
Molecular Weight | 230.73400 |
Exact Mass | 230.11900 |
PSA | 23.55000 |
LogP | 2.17130 |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
RIDADR | UN 3261 8 / PGIII |
HS Code | 2933399090 |
~96% 103816-19-9 |
Literature: CADILA HEALTHCARE LIMITED Patent: EP2341046 A2, 2011 ; Location in patent: Page/Page column 9 ; |
~% 103816-19-9 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 39, # 6 p. 1446 - 1454 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |